Ind-Swift [INDSWFTLAB] vs Sakar Healthcare [SAKAR] Detailed Stock Comparison
Ind-Swift
NSE
Loading...
Sakar Healthcare
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Ind-Swift wins in 10 metrics, Sakar Healthcare wins in 7 metrics, with 0 ties. Ind-Swift appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ind-Swift | Sakar Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 1.69 | 40.96 | Ind-Swift |
| Price-to-Book Ratio | 0.58 | 2.47 | Ind-Swift |
| Debt-to-Equity Ratio | 3.48 | 30.26 | Ind-Swift |
| PEG Ratio | -0.02 | N/A | N/A |
| EV/EBITDA | -15.30 | 15.55 | Ind-Swift |
| Profit Margin (TTM) | 40.55% | 10.45% | Ind-Swift |
| Operating Margin (TTM) | -2.01% | 13.53% | Sakar Healthcare |
| EBITDA Margin (TTM) | N/A | 13.53% | N/A |
| Return on Equity | 45.19% | 6.13% | Ind-Swift |
| Return on Assets (TTM) | 36.13% | 4.21% | Ind-Swift |
| Free Cash Flow (TTM) | $-2.08B | $17.50M | Sakar Healthcare |
| 1-Year Return | -25.95% | 3.22% | Sakar Healthcare |
| Price-to-Sales Ratio (TTM) | 1.33 | 3.74 | Ind-Swift |
| Enterprise Value | $2.69B | $8.07B | Sakar Healthcare |
| EV/Revenue Ratio | 0.47 | 4.27 | Ind-Swift |
| Gross Profit Margin (TTM) | 28.22% | 70.80% | Sakar Healthcare |
| Revenue per Share (TTM) | $84 | $86 | Sakar Healthcare |
| Earnings per Share (Diluted) | $59.91 | $7.95 | Ind-Swift |
| Beta (Stock Volatility) | 0.44 | 0.06 | Sakar Healthcare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ind-Swift vs Sakar Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ind-Swift | -0.94% | 1.07% | -4.55% | 30.20% | 10.36% | -7.78% |
| Sakar Healthcare | -0.74% | -3.35% | -4.79% | 4.79% | 39.17% | 7.97% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ind-Swift | -25.95% | 62.30% | 164.86% | 196.61% | 7.97% | -50.91% |
| Sakar Healthcare | 3.22% | 73.73% | 472.32% | 442.75% | 442.75% | 442.75% |
Performance & Financial Health Analysis: Ind-Swift vs Sakar Healthcare
| Metric | INDSWFTLAB | SAKAR |
|---|---|---|
| Market Information | ||
| Market Cap | ₹7.53B | ₹7.08B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 73,088 | 7,030 |
| 90 Day Avg. Volume | 137,664 | 13,028 |
| Last Close | ₹100.49 | ₹323.25 |
| 52 Week Range | ₹68.72 - ₹158.56 | ₹210.10 - ₹380.80 |
| % from 52W High | -36.62% | -15.11% |
| All-Time High | ₹296.50 (Dec 20, 2004) | ₹479.00 (Jan 22, 2024) |
| % from All-Time High | -66.11% | -32.52% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 3.61% | 0.28% |
| Quarterly Earnings Growth | 8.38% | 0.94% |
| Financial Health | ||
| Profit Margin (TTM) | 0.41% | 0.10% |
| Operating Margin (TTM) | -0.02% | 0.14% |
| Return on Equity (TTM) | 0.45% | 0.06% |
| Debt to Equity (MRQ) | 3.48 | 30.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹173.94 | ₹131.81 |
| Cash per Share (MRQ) | ₹68.18 | ₹0.14 |
| Operating Cash Flow (TTM) | ₹-2,611,563,380 | ₹223.74M |
| Levered Free Cash Flow (TTM) | ₹4.21B | ₹175.02M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Ind-Swift vs Sakar Healthcare
| Metric | INDSWFTLAB | SAKAR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 1.69 | 40.96 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.02 | N/A |
| Price to Sales (TTM) | 1.33 | 3.74 |
| Price to Book (MRQ) | 0.58 | 2.47 |
| Market Capitalization | ||
| Market Capitalization | ₹7.53B | ₹7.08B |
| Enterprise Value | ₹2.69B | ₹8.07B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.47 | 4.27 |
| Enterprise to EBITDA | -15.30 | 15.55 |
| Risk & Other Metrics | ||
| Beta | 0.44 | 0.06 |
| Book Value per Share (MRQ) | ₹173.94 | ₹131.81 |
Financial Statements Comparison: Ind-Swift vs Sakar Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INDSWFTLAB | SAKAR |
|---|---|---|
| Revenue/Sales | ₹86.65M | ₹502.42M |
| Cost of Goods Sold | ₹62.20M | ₹146.71M |
| Gross Profit | ₹24.45M | ₹355.71M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-147.80M | ₹102.48M |
| EBITDA | ₹-7.21M | ₹159.07M |
| Pre-Tax Income | ₹-10.81M | ₹62.37M |
| Income Tax | ₹-10.76M | ₹4.75M |
| Net Income (Profit) | ₹62,000 | ₹57.61M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INDSWFTLAB | SAKAR |
|---|---|---|
| Cash & Equivalents | ₹4.38B | ₹1.02M |
| Total Current Assets | ₹5.87B | ₹887.27M |
| Total Current Liabilities | ₹1.64B | ₹631.86M |
| Long-Term Debt | ₹109.02M | ₹535.94M |
| Total Shareholders Equity | ₹10.12B | ₹2.85B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹50.19M | ₹3.04B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INDSWFTLAB | SAKAR |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INDSWFTLAB | SAKAR |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 73,088 | 7,030 |
| Average Daily Volume (90 Day) | 137,664 | 13,028 |
| Shares Outstanding | 59.09M | 21.75M |
| Float Shares | 27.08M | 10.52M |
| % Held by Insiders | 0.57% | N/A |
| % Held by Institutions | 0.06% | N/A |
Dividend Analysis & Yield Comparison: Ind-Swift vs Sakar Healthcare
| Metric | INDSWFTLAB | SAKAR |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |